IIL currently fits my investment style and criteria perfectly. Long lead time till Phase III results (2H 2015) with plenty of mini-milestones along the way that will give clues as to how euphoric the market will get as we draw closer to clinical results. It also has the benefit of data from the compassionate group becoming available in one form or another, which will again give clues as to what the market will expect.
Also a tight share register and fully cashed-up to see them through till the end of Phase III.
IPOd at 20c and I've been buying every time it drops below that price. Sold some at 28c then bought back at 18c. Should have plenty of opportunity to keep doing this for several months but for that reason it's also a great time to build a LT position, along with some traders.
